Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 2 (2005), Issue 4 (April)

1. Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature.
   Pediatr Dev Pathol, 8(1): 52-60. [Abstract] [Full-text]
2. Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand.
   Blood, 105(8): 3206-13. [Abstract] [Full-text]
3. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis.
   J Exp Med, 201(7): 1089-99. [Abstract] [Full-text]
4. Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors.
   Hum Mol Genet, 14: R93-R100. [Abstract] [Full-text]
5. An assessment of incomplete facial Basal cell carcinoma excision.
   J Coll Physicians Surg Pak, 15(3): 149-51. [Abstract] [Full-text]
6. Sebaceous gland carcinoma of the eyelid presenting as a conjunctival papilloma.
   Clin Experiment Ophthalmol, 33(2): 197-8. [Abstract] [Full-text]
7. Squamous cell carcinoma and basal cell carcinoma arising in a naevus sebaceous of Jadassohn: case report and literature review.
   Clin Exp Dermatol, 30(3): 259-60. [Abstract] [Full-text]
8. Epithelioid haemangioma in association with a deep arteriovenous malformation.
   Clin Exp Dermatol, 30(3): 238-40. [Abstract] [Full-text]
9. An evaluation of the role of a store-and-forward teledermatology system in skin cancer diagnosis and management.
   Clin Exp Dermatol, 30(3): 209-14. [Abstract] [Full-text]
10. Clear cell hidradenoma of the skin-a third tumor type with a t(11;19)--associated TORC1-MAML2 gene fusion.
    Genes Chromosomes Cancer, 43(2): 202-5. [Abstract] [Full-text]
11. Mending human genes: a job for a lifetime.
    DNA Repair (Amst), 4(5): 635-8. [Abstract] [Full-text]
12. CD10 is expressed in cutaneous clear cell lesions of different histogenesis.
    J Cutan Pathol, 32(5): 348-51. [Abstract] [Full-text]
13. Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors.
    J Cutan Pathol, 32(5): 340-7. [Abstract] [Full-text]
14. Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction.
    J Cutan Pathol, 32(5): 334-9. [Abstract] [Full-text]
15. Nucleolar organizer region staining patterns in paraffin-embedded tissue cells from human skin cancers.
    J Cutan Pathol, 32(5): 323-8. [Abstract] [Full-text]
16. Tobacco smoking, snuff dipping and the risk of cutaneous squamous cell carcinoma: a nationwide cohort study in Sweden.
    Br J Cancer, 92(7): 1326-8. [Abstract] [Full-text]
17. Automated melanoma detection with a novel multispectral imaging system: results of a prospective study.
    Phys Med Biol, 50(8): 1675-87. [Abstract] [Full-text]
18. Reconstruction of complex facial defects after radical resection of advanced skin cancers.
    Clin Plast Surg, 32(2): 275-85. [Abstract] [Full-text]
19. Melanoma.
    Clin Plast Surg, 32(2): 249-59. [Abstract] [Full-text]
20. Nonmelanoma skin cancer.
    Clin Plast Surg, 32(2): 237-48. [Abstract] [Full-text]
21. Premalignant and early squamous cell carcinoma.
    Clin Plast Surg, 32(2): 223-35. [Abstract] [Full-text]
22. [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin.
    Oncogene, 24(15): 2558-67. [Abstract] [Full-text]
23. Repair of small nasal defects.
    Facial Plast Surg Clin North Am, 13(2): 283-99, vi. [Abstract] [Full-text]
24. Cutaneous lesions: benign and malignant.
    Facial Plast Surg Clin North Am, 13(2): 195-202, v. [Abstract] [Full-text]
25. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy.
    Int J Radiat Oncol Biol Phys, 61(5): 1446-53. [Abstract] [Full-text]
26. Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis.
    J Invest Dermatol, 124(4): 849-56. [Abstract] [Full-text]
27. Gangliosides inhibit urokinase-type plasminogen activator (uPA)-dependent squamous carcinoma cell migration by preventing uPA receptor/alphabeta integrin/epidermal growth factor receptor interactions.
    J Invest Dermatol, 124(4): 839-48. [Abstract] [Full-text]
28. T-cadherin negatively regulates the proliferation of cutaneous squamous carcinoma cells.
    J Invest Dermatol, 124(4): 833-8. [Abstract] [Full-text]
29. Melanoma cells express elevated levels of phosphorylated histone H2AX foci.
    J Invest Dermatol, 124(4): 807-17. [Abstract] [Full-text]
30. Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas.
    J Invest Dermatol, 124(4): 741-50. [Abstract] [Full-text]
31. The effect of a school-based sun protection intervention on the development of melanocytic nevi in children: 6-year follow-up.
    Cancer Epidemiol Biomarkers Prev, 14(4): 977-80. [Abstract] [Full-text]
32. No Evidence for BRAF as a melanoma/nevus susceptibility gene.
    Cancer Epidemiol Biomarkers Prev, 14(4): 913-8. [Abstract] [Full-text]
33. Fatty acid composition of red blood cell membranes and risk of squamous cell carcinoma of the skin.
    Cancer Epidemiol Biomarkers Prev, 14(4): 906-12. [Abstract] [Full-text]
34. Papillary endothelial hyperplasia and dilated lymphatic vessels in bullous pilomatricoma.
    Acta Derm Venereol, 85(2): 160-3. [Abstract] [Full-text]
35. Cytokine gene polymorphisms in patch-stage mycosis fungoides.
    Acta Derm Venereol, 85(2): 109-12. [Abstract] [Full-text]
36. Placental site trophoblastic tumor presenting as subaponeurotic metastasis.
    Int J Gynecol Cancer, 15(2): 385-8. [Abstract] [Full-text]
37. Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma.
    Ann Surg Oncol, 12(3): 207-13. [Abstract] [Full-text]
38. Popliteal lymph node dissection.
    Ann Surg Oncol, 12(2): 189-93. [Abstract] [Full-text]
39. Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma.
    Ann Surg Oncol, 12(1): 18-23. [Abstract] [Full-text]
40. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
    Cancer, 103(8): 1693-700. [Abstract] [Full-text]
41. Selective sensitivity to wasabi-derived 6-(methylsulfinyl)hexyl isothiocyanate of human breast cancer and melanoma cell lines studied in vitro.
    Cancer Detect Prev, 29(2): 155-60. [Abstract] [Full-text]
42. A case of linear epidermal naevus presenting as genital warts--a cautionary tale.
    Int J STD AIDS, 16(3): 267-9. [Abstract] [Full-text]
43. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.
    Hum Mol Genet, 14(9): 1153-60. [Abstract] [Full-text]
44. Risk factors and individual probabilities of melanoma for whites.
    J Clin Oncol, 23(12): 2669-75. [Abstract] [Full-text]
45. Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod.
    Arch Dermatol, 141(4): 510-4. [Abstract] [Full-text]
46. Clinical recognition of actinic keratoses in a high-risk population: how good are we?
    Arch Dermatol, 141(4): 507-9. [Abstract] [Full-text]
47. A content analysis of news coverage of skin cancer prevention and detection, 1979 to 2003.
    Arch Dermatol, 141(4): 491-6. [Abstract] [Full-text]
48. Association of UV index, latitude, and melanoma incidence in nonwhite populations--US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001.
    Arch Dermatol, 141(4): 477-81. [Abstract] [Full-text]
49. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.
    Arch Dermatol, 141(4): 456-64. [Abstract] [Full-text]
50. Cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort with regard to tumor site.
    Arch Dermatol, 141(4): 447-51. [Abstract] [Full-text]
51. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium.
    Arch Dermatol, 141(4): 440-4. [Abstract] [Full-text]
52. First prospective study of the recognition process of melanoma in dermatological practice.
    Arch Dermatol, 141(4): 434-8. [Abstract] [Full-text]
53. Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival.
    Clin Cancer Res, 11(8): 2991-7. [Abstract] [Full-text]
54. Melanoma treatment update.
    Dermatol Clin, 23(2): 323-33. [Abstract] [Full-text]
55. FNA diagnosis of primary adult onset lymphocutaneous Langerhans' cell histiocytosis masquerading as deep fungal mycosis.
    Diagn Cytopathol, 32(5): 292-5. [Abstract] [Full-text]
56. FNA diagnosis of dermatofibrosarcoma protuberans.
    Diagn Cytopathol, 32(5): 299-302. [Abstract] [Full-text]
57. Melanoma genetics and the development of rational therapeutics.
    J Clin Invest, 115(4): 813-24. [Abstract] [Full-text]
58. Immunopathogenesis and therapy of cutaneous T cell lymphoma.
    J Clin Invest, 115(4): 798-812. [Abstract] [Full-text]
59. Cutaneous collision tumour (melanocytic naevus, basal cell carcinoma, seborrhoeic keratosis): a clinical, dermoscopic and pathological case report.
    Br J Dermatol, 152(4): 787-90. [Abstract] [Full-text]
60. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma.
    Br J Dermatol, 152(4): 765-72. [Abstract] [Full-text]
61. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
    Br J Dermatol, 152(4): 755-7. [Abstract] [Full-text]
62. Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
    Br J Dermatol, 152(4): 720-6. [Abstract] [Full-text]
63. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
    Br J Dermatol, 152(4): 690-6. [Abstract] [Full-text]
64. Circulating vascular endothelial growth factor in cutaneous malignant melanoma.
    Br J Dermatol, 152(4): 685-9. [Abstract] [Full-text]
65. Dysplastic naevus vs. in situ melanoma: digital dermoscopy analysis.
    Br J Dermatol, 152(4): 679-84. [Abstract] [Full-text]
66. Desmoplastic malignant melanoma: a systematic review.
    Br J Dermatol, 152(4): 673-8. [Abstract] [Full-text]
67. Inverted malignant pilomatricoma of the neck.
    Eur Arch Otorhinolaryngol, 262(4): 269-71. [Abstract] [Full-text]
68. Cutaneous clear cell myomelanocytic tumour: a new member of the growing family of perivascular epithelioid cell tumours (PEComas). Clinicopathological and immunohistochemical analysis of seven cases.
    Histopathology, 46(5): 498-504. [Abstract] [Full-text]
69. Approach to the treatment of cutaneous malignancy in HIV-infected patients.
    Dermatol Ther, 18(1): 77-86. [Abstract] [Full-text]
70. Management of nevi in transplant patients.
    Dermatol Ther, 18(1): 34-43. [Abstract] [Full-text]
71. Practical retinoid chemoprophylaxis in solid organ transplant recipients.
    Dermatol Ther, 18(1): 28-33. [Abstract] [Full-text]
72. Use of topical immunomodulators in organ transplant recipients.
    Dermatol Ther, 18(1): 19-27. [Abstract] [Full-text]
73. Management of skin cancer in solid organ transplant recipients.
    Dermatol Ther, 18(1): 12-8. [Abstract] [Full-text]
74. The relative effects of different systemic immunosuppressives on skin cancer development in organ transplant patients.
    Dermatol Ther, 18(1): 1-11. [Abstract] [Full-text]
75. Cutaneous extraskeletal mesenchymal chondrosarcoma in a cat.
    Vet Dermatol, 16(2): 121-4. [Abstract] [Full-text]
76. Heat shock proteins expression in canine intracutaneous cornifying epithelioma and squamous cell carcinoma.
    Vet Dermatol, 16(2): 108-16. [Abstract] [Full-text]
77. Rare complication of Q fever vaccination.
    Australas J Dermatol, 46(2): 124-5. [Abstract] [Full-text]
78. Atrophic dermatofibrosarcoma protuberans.
    Australas J Dermatol, 46(2): 114-7. [Abstract] [Full-text]
79. Predictors of quality of life in newly diagnosed melanoma and breast cancer patients.
    Ann Oncol, 16(5): 805-16. [Abstract] [Full-text]
80. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling.
    Blood, 105(9): 3671-8. [Abstract] [Full-text]
81. Different manifestations of malignant melanoma in the breast: a report of 12 cases and a review of the literature.
    Jpn J Clin Oncol, 35(4): 202-6. [Abstract] [Full-text]
82. Merkel cell carcinoma in the orbitopalpebral region.
    Scand J Plast Reconstr Surg Hand Surg, 39(1): 48-52. [Abstract] [Full-text]
83. Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience.
    Transplant Proc, 37(2): 962-3. [Abstract] [Full-text]
84. Combining multispectral polarized light imaging and confocal microscopy for localization of nonmelanoma skin cancer.
    J Biomed Opt, 10(1): 14011. [Abstract] [Full-text]
85. CCR10 is expressed in cutaneous T-cell lymphoma.
    Int J Cancer, 115(4): 641-7. [Abstract] [Full-text]
86. Assessing the perceived importance of skin cancer: how question-order effects are influenced by issue involvement.
    Health Educ Behav, 32(3): 398-412. [Abstract] [Full-text]
87. Significance of serum S-100B in melanoma patients before and after sentinel node biopsy.
    J Surg Oncol, 90(2): 66-9; discussion 69-70. [Abstract] [Full-text]
88. Apoptosis in CD30-positive lymphoproliferative disorders of the skin.
    Exp Dermatol, 14(5): 380-5. [Abstract] [Full-text]
89. Downregulation of NDUFA1 and other oxidative phosphorylation-related genes is a consistent feature of basal cell carcinoma.
    Exp Dermatol, 14(5): 336-48. [Abstract] [Full-text]
90. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation.
    J Invest Dermatol, 124(5): 919-20. [Abstract] [Full-text]
91. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Tissue Antigens, 65(5): 419-28. [Abstract] [Full-text]
92. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
    J Clin Pathol, 58(5): 453-6. [Abstract] [Full-text]
93. Pilomatrixoma breast mimicking carcinoma.
    J Coll Physicians Surg Pak, 15(4): 248-9. [Abstract] [Full-text]
94. Dermatofibrosarcoma protuberans.
    J Coll Physicians Surg Pak, 15(4): 246-7. [Abstract] [Full-text]
95. Hobnail haemangioma associated with the menstrual cycle.
    J Eur Acad Dermatol Venereol, 19(3): 367-9. [Abstract] [Full-text]
96. Early detection of cutaneous angiosarcoma of the face and scalp and treatment with placitaxel.
    J Eur Acad Dermatol Venereol, 19(3): 357-9. [Abstract] [Full-text]
97. Kaposi sarcoma associated with lipoedema.
    J Eur Acad Dermatol Venereol, 19(3): 352-4. [Abstract] [Full-text]
98. Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination.
    J Eur Acad Dermatol Venereol, 19(3): 332-9. [Abstract] [Full-text]
99. Randomized trial of hyperthermia and radiation for superficial tumors.
    J Clin Oncol, 23(13): 3079-85. [Abstract] [Full-text]
100. Role of the CDKN2A locus in patients with multiple primary melanomas.
     J Clin Oncol, 23(13): 3043-51. [Abstract] [Full-text]
101. Malignant melanoma and filariasis: a coexistence or an association?
     Int J Low Extrem Wounds, 4(1): 60-4. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.